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n Abstract Multipotent stem cells are clonal cells that self-renew as well as dif-
ferentiate to regenerate adult tissues. Whereas stem cells and their fates are known by
unique genetic marker studies, the fate and function of these cells are best studied by
their prospective isolation. This review is about the properties of various highly puri-
fied tissue-specific multipotent stem cells and purified oligolineage progenitors. We
contend that unless the stem or progenitor cells in question have been purified to near
homogeneity, one cannot know whether their generation of expected (or unexpected)
progeny is a property of a known cell type. It is interesting that in the hematopoietic
system the only long-term self-renewing cells in the stem and progenitors pool are the
hematopoietic stem cells. This fact is discussed in the context of normal and leukemic
hematopoiesis.
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INTRODUCTION
Significant attention has been directed toward research in the general area of stem
cells. Although the level of activity is high, there is considerable confusion and
disagreement among investigators as to the properties of stem cells. Part of the con-
fusion can be traced to the different definitions that are used to define stem cells, the
methods and procedures used to characterize the starting population, and the state
of populations of cells that are evaluated. In this review, we first take an historical
perspective, emphasizing the rationale for the requirement of clonogenic assays in
defining a stem cell, with special reference to the hematopoietic system. We next
describe how this approach can be extended to other lineages such as nervous sys-
tem tissues. With this background, we take up a current area of controversy in stem
cell biology—that of transdifferentiation and/or dedifferentiation—and describe
how a clonogenic approach to stem cell identification can help to defuse or untangle
the current debate.
HEMATOPOIETIC STEM CELLS AS THE MODEL
Stem cells are currently defined as single cells that are clonal precursors of both
more stem cells of the same type, as well as a defined set of differentiated progeny
(for reviews, see Gage 2000; Weissman 2000a,b). The first genetic evidence that
stem cells exist came from the studies of Till, McCulloch, Wu, Becker, and
Siminovitch on blood-forming (hematopoietic) stem and progenitor cells (Till &
McCulloch 1961). In these experiments, random chromosome markers were gener-
ated in donor bone marrow by radiation, and colonies of progeny cells, each derived
from a single clonogenic precursor, were found in the spleens of conditioned hosts;
these colonies always contained differentiated cells of the myeloerythroid series
and often contained cells that could be used to reconstitute secondary hosts to
produce all blood cell lineages (Becker et al. 1963, Wu et al. 1968). Although the
concept of stem cells has been extended to many other tissues, it is our contention
that only rarely have stem cells been identified as clonogenic precursors that in-
clude in their progeny both self-renewed stem cells and differentiated progeny.
Just as genetics provides evidence for the nature of a particular event, it does not
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provide for the purification of the gene, the gene product, or in this case the stem
cell that genetic evidence implied. Although biochemistry is the discipline that has
provided purification of genes and molecules, a new field of cellular purification
was required to allow the prospective isolation of stem and progenitor cells.
To provide for the first isolation of mouse hematopoietic stem cells (HSC), it
was necessary to develop assays for the clonal precursors of all known differen-
tiated blood cell types, including myeloerythroid cells (Till & McCulloch 1961),
B lineage cells (Muller-Sieburg et al. 1986, Whitlock et al. 1987), and T lineage
cells (Ezine et al. 1984). The second step required for the isolation of HSC was
the production of monoclonal antibodies to cell surface molecules found on bone
marrow cells. The third requirement was for high-speed sorting of cells bearing
and lacking combinations of monoclonal antibody-defined surface determinants
(Muller-Sieburg et al. 1986, Spangrude et al. 1988).
An important step in the isolation of HSC was the finding that the clono-
genic precursors in all three of the above assays were contained within the pop-
ulation of cells that lacked or had only very low levels of markers of lineage
commitment to various blood cell types (Muller-Sieburg et al. 1986). Thus HSC
are lineage negative (Lin−) for markers found on T cells, B cells, granulocytes,
monocytes/macrophages, erythroid cells, natural killer cells, etc. Mouse HSC
are positive for two cell surface glycophosphatidyl inositol-linked immunoglob-
ulin superfamily molecules, Sca-1 (Ly6A/E) and Thy-1 (Spangrude et al. 1988).
They are also positive for the c-kit receptor tyrosine kinase (Ikuta & Weissman
1992), although in instances in which endogenous or exogenous c-kit ligand
(SLF) is abundant, the c-kit marker is partially down-modulated. These c-kitC (K),
Thy-1.1lo (T), Lin−/lo (L), Sca-1hi (S), bone marrow (BM) cells are, at the clonal
level, all multipotent, but can be subdivided into three subpopulations by surface
markers and by degree of self-renewal (Morrison & Weissman 1994): (a) The
totally Lin− subset (many but not all of which are CD34lo) consists of perpetually
self-renewing long-term (LT) HSC. (b) The Mac-1lo subset of KTLS cells is a
uniform population of multipotent cells that self-renew in vivo upon transplanta-
tion for 6 weeks, which is the end of their productive lifespan (ST-HSC). (c)
The Mac-1lo CD34lo subset of KTLS are clonogenic multipotent precursors whose
self-renewal potential is short and, under transplant conditions difficult to detect;
these cells are called multipotent progenitors (MPP). LT-HSC give rise to ST-HSC,
which in turn give rise to MPP, and we cannot detect dedifferentiation in that lin-
eage (Morrison et al. 1997a). That is, ST-HSC never give rise to LT-HSC, and MPP
never give rise to either LT-HSC or ST-HSC. KTLS cells can be mobilized from
BM to blood; treatment of a donor with cytoxan plus G-CSF causes all HSC to
enter the cell cycle, and many daughter HSCs are released to the blood (Morrison
et al. 1997b).
KTLS cells are the only cells within mouse BM that will both radioprotect
and reconstitute all blood cell lineages (Uchida & Weissman 1992). Increasing
the dose of KTLS cells transplanted into lethally irradiated hosts shortens the
time to the appearance of donor-derived blood cells and elements; however, in the
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syngeneic (transplant of cells between mice of the same strain) setting, increasing
the dose even 10-fold above that required for engraftment by 10 days neither short-
ens the time to engraftment further nor has any attendant toxicities (Uchida et al.
1998). These experiments provide two important points for the kind of regenera-
tive medicine that will result from stem cell therapies; first, only stem cells (even
LT-HSC) are required for rapid engraftment and, second, the body regulates the
cellular output from transplanted HSC. Even in lethally irradiated mice there are
immune barriers to the transplantation of HSC from genetically different, allo-
geneic donors. For example, the minimal HSC dose to just radioprotect 95% of
irradiated hosts is 100 cells in the syngeneic setting, about 500 cells in major
histocompatibility complex (MHC) -matched but otherwise unmatched donor-
recipient combinations, and 1–3000 HSC in a variety of donor host combinations
that are neither MHC nor otherwise matched (Shizuru et al. 1996). Because HSC
lack contaminating T lymphocytes, these allogeneic chimeras do not suffer the
consequences of a T cell-mediated graft versus host (GvH) response (Shizuru
et al. 1996). These allogeneic chimeras are also specifically tolerant for the life of
organ, tissue, or other tissue-specific stem cell transplants from the HSC genotype
donor (Gandy & Weissman 1998, Shizuru et al. 2000).
Human HSC have been isolated from umbilical cord blood, fetal liver, fetal bone
marrow, adult bone marrow, and mobilized peripheral blood (MPB). These cells
are CD34C, Thy-1C, Lin¡, c-kitlo, and CD38¡ (Baum et al. 1992, Tsukamoto
et al. 1995), although there are some indications that in humans there is also a
rare CD34¡/lo subset of this general population that has HSC activity. Prospective
isolation of CD34C ThyC cells is an efficient method of purifying them away from
cancer cells present in the MPB (Negrin et al. 2000). Successful transplantation of
cancer-depleted or cancer-deficient MPB HSC has resulted in donor-derived rescue
of fully myelo-ablated cancer patients (stage IV breast cancer, non-Hodgkin’s
lymphoma, multiple myeloma) in the same dose- dependent fashion that KTLS
cells provided in mouse studies (Michallet et al. 2000, Negrin et al. 2000).
IDENTIFICATION AND ISOLATION OF HEMATOPOIETIC
PROGENITOR CELLS
The same methodology that allowed prospective isolation of mouse HSC has
been used to identify and isolate mouse hematopoietic oligolineage progenitors
(Akashi et al. 2000, Kondo et al. 1997). As shown in Figure 1, downstream of
the clonogenic multipotent pool are two developmental choices, either the com-
mon myeloid progenitor (CMP) or the common lymphocyte progenitor (CLP).
Each of these cell types has been isolated to homogeneity, each is a clonal pre-
cursor of a limited subset of progeny, and each has a distinct expressed gene profile
(Akashi et al. 2000; Metcalf 1989, 1991). Two kinds of cytokine cell surface recep-
tors are good markers of the commitment to the myeloid or the lymphoid pathway:
CMP, like HSC, express granulocyte macrophage cell-stimulating factor receptors
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(GM-CSFR) and do not express cell surface IL-7 receptor, whereas CLP express
cell surface IL-7Rγ c but do not express GM-CSFR (Kondo et al. 1997). Each
CMP can give rise to even more lineage-restricted progenitors, either the granu-
locyte/monocyte progenitor (GMP) or the megakaryocyte/erythrocyte progenitor
(MEP). Under normal conditions, these cells are absolutely lineage restricted and
upon transplantation do not detectably self-renew (Kondo et al. 1997). They must,
therefore, be derived continually from HSC, and in the steady state, all HSC (in-
cluding LT-HSC) will enter the cell cycle in a regulated fashion (Cheshier et al.
1999). For example, 8% of the LT-HSC enter the cell cycle per day at random,
whereas higher percentages of ST-HSC, MPP, CLP, and CMP enter the cell cycle
each day (Morrison & Weissman 1994, Kondo et al. 1997, Akashi et al. 2000,
Cheshier et al. 1999). The GMP and MEP progeny of CMP are also virtually all in
cell cycle (Akashi et al. 2000). Following a variety of stimuli, all LT-HSC can enter
the cell cycle in vivo in largely self-renewing divisions (Morrison et al. 1997b,
Wright et al. 2001). However, in vitro expansion of KTLS HSC and their subsets
by self-renewal has not yet been reliably accomplished.
SELF-RENEWAL, STEM CELLS, AND CANCER
It is important to note that long-term self-renewal is limited to LT-HSC in the
hematopoietic stem and progenitor pool. Despite intense investigation, genetic
control of self-renewal and LT-HSC expansion remains a mystery. It is also im-
portant to note that all mouse leukemias, no matter what stage of differentiation
marks the leukemogenic stem cell, have also gained the properties of self-renewal,
as have all other clonogenic cancer cells. It is crucial, therefore, to define the ge-
netic control of self-renewal in this class of stem cells, as well as the leukemias
derived from their progeny.
There are several important points about the fact that normally only stem
cells self-renew perpetually and that leukemias and cancers contain leukemic
(Bonnet & Dick 1997) and cancer stem cells that have gained (or retained) the pro-
perty of self-renewal. Several leukemias contain leukemia-specific chromosomal
translocations, deletions, amplifications , or inversions (e.g., Miyamoto et al. 2000,
Fialkow et al. 1991, Seale et al. 1996, Faderl et al. 1999, Hagemeijer et al. 1984). In
many of these leukemias, the critical chromosomal aberration is in the HSC pool,
varying from a fraction to all HSC. Yet in many of these cases, the HSC are not
malignant (Miyamoto et al. 2000). We have proposed that although in acute myel-
ogenous leukemia the translocation (AML-1; ETO) is in HSC, the final steps in
leukemia progression have occurred downstream of HSC (Miyamoto et al. 2000).
This makes sense. If HSC are the only hematopoietic cells that normally self-renew,
then the only genetic alterations in leukemia progression that can be retained in the
hematopoietic system must accumulate in HSC, until one or more events permit a
downstream progenitor class to self-renew. After that, both self-renewing popula-
tions can accumulate transforming mutations. The result, presumably true for all
malignancies and not just leukemias, is that either the normal stem cell class or a
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downstream cell (Miyamoto et al. 2000, Bonnet & Dick 1997) could gain the ulti-
mate stage of malignant progression. In one case, the malignancy is in stem cells,
and in the other, a downstream progenitor is transformed to the cancer stem cells.
An additional point is that within a leukemia or a cancer, the cancer stem cell may
not exclusively self-renew but may simply increase the frequency of self-renewing
divisions. The consequence of this possibility is that the cancer/leukemia stem cell
could be a minority of cells in the lesion and in its clone. Given this possibility,
it will be essential to identify and isolate the malignant stem cell for each type of
malignancy because only this cell has the critical gene expression profile of the
true cancer cell or the critical tumor antigens against which effective immunity
must be directed.
CENTRAL NERVOUS SYSTEM (CNS) STEM CELLS
Although the conventional wisdom has been that regeneration of brain cells can-
not occur after a certain age, the pioneering experiments of Altman (Altman 1962,
Altman & Das 1965), Alvarez-Buylla (Lois & Alvarez-Buylla 1993, 1994), Bartlett
(Kilpatrick & Bartlett 1993, 1995), Goldman & Nottebohm (1983), and Gage
(Gage 2000, Kuhn et al. 1997, Kempermann et al. 1997, Eriksson et al. 1998) have
demonstrated regions of continued high-rate neurogenesis throughout life in ro-
dents and humans. These regions include the subventricular zones (SVZ) bordering
(at least) the lateral ventricles and the dentate gyrus (DG) in the hippocampus (Gage
2000). Although it is conceivable that low-rate proliferation might occur in adult
brains in different regions, the evidence is not yet in. The methodologies that led to
an understanding that CNS stem cells must exist and therefore could be prospec-
tively isolated began with the demonstration that cells derived from rodent fetal
brain or adult SVZ or adult DG cells can grow in vitro in the presence of defined fac-
tors such as bFGF and EGF (Reynolds & Weiss 1992, Richards et al. 1992, Temple
& Alvarez-Buylla 1999, Temple & Davis 1994, Gritti et al. 1996, Johe et al. 1996,
Kalyani et al. 1997, Mayer-Proschel et al. 1997, Ray et al. 1993, Davis & Temple
1994). These cells can grow as adherent monolayers or as non-surface adherent but
self-associating neurospheres (Reynolds & Weiss 1992, Temple & Alvarez-Buylla
1999, Temple & Davis 1994, Gritti et al. 1996, Ray et al. 1993, Davis & Temple
1994). Embryonic stem (ES) cell cultures have been used as a source of subsets
of CNS-committed cultures (Brustle et al. 1998, 1999). Retroviral marking of ad-
herent rodent brain cell cultures revealed the presence of clonally marked cells
that can both self-renew and give rise to neurons, astrocytes, and oligodendrocytes
(Palmer et al. 1997). Transplantation of these clonally marked rodent brain cell
cultures into the hippocampus or into the subventricular zone (SVZ) or even into
the newborn rat eye has revealed that these cells might include a population of
CNS stem cells capable of responding to local microenvironmental cues (Gage
2000; Brustle et al. 1998, 1999; Flax et al. 1998; Morshead et al. 1994; Johansson
et al. 1999; Snyder 1994; Reynolds & Weiss 1996). When it was found that human
fetal brain cells could also respond to these growth factors by forming neurosphere
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cultures (Carpenter et al. 1999), the possible existence of a neurosphere-initiating
stem cell was proposed (Uchida et al. 2000). Using the same methodologies of
clonogenic assays (the neurosphere-initiating cells), i.e., the production and use
of cell surface monoclonal antibodies to cell surface determinants and high-speed
fluorescent-activated cell sorting (FACS), led to prospective isolation of candi-
date human fetal brain CNS stem cells (Uchida et al. 2000). Neurospheres derived
from CD133C, CD24−/lo, CD34−, CD45− c-kit− candidate CNS stem cells could be
dissociated and transplanted into the lateral ventricles of genetically immunodefi-
cient newborn NOD-SCID mice (Uchida et al. 2000). The newborn mouse brain is
obviously still undergoing much neurogenesis, and so one could hope that the
engrafted cells would participate in such neurogenesis. In fact, robust engraftment
was seen for the life of the recipients. In both the SVZ and DG, even 7 months
later, human cells, similar to their mouse counterparts, were significantly engaged
in continued cell proliferation evidenced by their expression of the proliferation-
specific marker Ki67. In zones where mouse cells were migrating away from the
sites of proliferation, human cells were found for as long as 7 months or more,
where they could be followed, differentiating en route. In zones where mouse cells
had differentiated into neurons and glia, human cells also showed morphologi-
cal evidence of having differentiated into neurons and glia. Standard histological
examination of these chimeric mouse brains showed no easily detectable abnormal-
ities such as proliferative or neoplastic cell foci or mal-development. In addition,
the progeny of these cells could be found throughout the mouse brain, including
the corpus callosum, the striatum, the mid-brain, the cerebellum, and even the
cerebral cortex. Injection of similar neurospheres into the SVZ or DG of adult
immunosuppressed rats had also been shown to result in site-specific and appar-
ently appropriate human cell proliferation, cell migration, and cell differentiation
(Fricker et al. 1999). Gene modification of these adherent cells (Palmer et al. 1997)
and neurosphere cultures has been demonstrated; it is reasonable to propose that
if gene modification of CNS stem cells in vitro leads to appropriately regulated
gene expression upon transplantation, this will add a potent new tool to the arma-
mentarium of stem cell biologists, developmental biologists, and neurobiologists
who wish to study the development and function of rodent and human brain cells
(reviewed in Anderson 2001). It also is to be expected that by using the techniques
described above for the identification of downstream hematopoietic oligolineage
progenitors, one should be able to begin to identify and place in lineages both
human and rodent CNS progenitors of the major lineages and sublineages.
IDENTIFICATION AND ISOLATION OF PERIPHERAL
NERVOUS SYSTEM (PNS) STEM CELLS
Using in vitro assays for the outcome of differentiation of neural crest cells,
Anderson et al. sought the phenotype of PNS stem cells (Stemple & Anderson
1992). The vertebrate fetal neural crest gives rise to cells that contribute to all head
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structures, as well as to the peripheral nervous system, the adrenal medulla, most
if not all smooth muscle cells, melanocytes, and the visceral nervous system
(Anderson et al. 2001). Cultured populations of neural crest-derived cells con-
tained a subset of P75C PO− PNS stem cells capable of multilineage maturation.
Such cells could be prospectively isolated from the fetal neural crest as well as
from late fetal tissues, such as rodent sciatic nerve, using similar markers, and
could be shown to be self-renewing clonogenic precursors of peripheral neurons,
glia (Schwann cells), and smooth muscle cells (Morrison et al. 1999). Amazingly,
rat PNS-SC can be transplanted to chick embryos, where they retain their PNS de-
velopmental fates, apparently in response to microenvironmental cues that may be
evolutionarily conserved (White & Anderson 1999, White et al. 2001). Instructive
differentiation factors for each of these differentiated derivatives have been identi-
fied: GMP2 for autonomic neurons, TGF for smooth muscle cells, and Nrg-1 and
Notch for Schwann cells (Shah et al. 1994, 1996; Shah & Anderson 1997; Morrison
et al. 2000). It is not clear whether such neural crest stem cells can give rise to
all classes of PNS neurons, e.g., sensory as well as autonomic neurons. Similarly,
it is not clear whether multipotent CNS progenitors of neurons, astrocytes, and
oligodendrocytes can generate all classes of CNS neurons.
TRANSDIFFERENTIATION (TRANSDETERMINATION?)
OF STEM AND PROGENITOR CELLS
Many recent publications have claimed direct demonstration of transdifferentia-
tion of cells of one type of commitment to stem cells or differentiated cells for
distinct organs or tissues (Ferrari et al. 1998; Bjornson et al. 1999; Gussoni et al.
1999; Gritti et al. 1996; Clarke et al. 2000; Brazelton et al. 2000; Mezey et al. 2000;
Pereira et al. 1995; Petersen et al. 1999; Theise et al. 2000a,b). Before we examine
these data more closely, it is important to establish the minimum criteria for trans-
differentiation of stem cells (Morrison 2000; Anderson et al. 2001). Stem cells are
clonogenic cells capable of self-renewal and differentiation. Any claim for trans-
differentiation must begin with clonally identified tissue-specific stem cells and end
with isolation of stem cells, progenitor cells, and progeny in the transdifferentiated
organ or tissue. Unfortunately, a jargon exists in both the clinical and scientific
literature that equates bone marrow or mobilized peripheral blood or umbilical
cord blood transplants with HSC transplants. Similarly, a number of investigators
define neurospheres as stem cells without demonstrating that there are any stem
cells that can be prospectively isolated and then further assume that every cell in
the sphere is a stem cell when it is not clear what frequency are stem cells. The BM,
a complex tissue, contains a variety of cell types that include cells committed to
mesenchymal lineages (Pittenger et al. 1999), others to endothelial outcomes, and
still others to hematopoietic outcomes. Thus it is possible to unwittingly have stem
cells of one type of tissue, when in fact they could be stem cells from another tissue
or cells that are not stem cells at all but have undergone limited morphological
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differentiation similar to cell types in the host organ (Figure 2). We believe that a
claim of stem cell differentiation should include marking or isolating prospectively
the cell from the donor tissue and demonstrating, at the clonal level, that this a
stem cell from the donor, and that such cells have the capacity to repopulate and
regenerate stem cells, oligolineage progenitors, and differentiated and functional
progeny. It is not sufficient that rare progeny take on the morphological appear-
ance of tissue-specific differentiated cells. It is not sufficient if the repopulating
unit is not shown to be a clonogenic stem cell rather than a cluster of interacting
yet heterogeneous cells. Given these requirements and the examples described
in the legend in Figure 2, it is now appropriate to consider whether stem and/or
progenitor cells can be caused to transdifferentiate.
A Progenitor Cell Switch
Transplantation of mouse CLP into irradiated hosts reveals their ability only to pro-
duce all varieties of T cells, B cells, natural killer (NK) cells, and antigen-presenting
dendritic cells that do or do not express or express surface CD8fi (Traver et al.
2000). Adult BM CLP have never been shown either in vitro or in vivo to give
rise to granulocytes or macrophages (Kondo et al. 1997). However, if one induces
in or transfects to CLP, the GM CSF receptor, or genes that can induce the ex-
pression of that receptor, these cells can immediately respond by differentiating to
granulocytes and macrophages at the expense of generating lymphoid cells, even
at the clonal level (Kondo et al. 2000). While this may seem to be a limited trans-
differentiation, it is important to note that the morphological, functional, and gene
expression profiles of granulocytes and independently of macrophages are dramat-
ically different from those of the above-described lymphoid progeny. Interestingly,
culture of CLP in the presence of the lymphoid-specific cytokine IL-7 can, after
several days, render them resistant to the rescued transdifferentiation to GM cells
(Kondo et al. 2000). During that process, most of these cells in vitro commit to the
B cell lineage (Kondo et al. 1997, 2000). Freshly isolated early pro-B cells can-
not be transdifferentiated to GM cells, although very early pro-T cell types in the
thymus can (Kondo et al. 2000). At the stage of thymic T cell differentiation that
correlates to the rearrangement and surface expression of antigen-specific TCRfifl
heterodimers, the cells have become resistant to transdifferentiation to GM cells
(A. King, M. Kondo & I.L. Weissman, in preparation). It appears, therefore, that
in normal lineage commitments a phase of lymphoid-specific determination exists
wherein the normal outcomes are only of the lymphoid type, but the genome re-
mains sufficiently plastic for further developmental stages to be rescued from one
set of phenotypes to another. This might be a general principle.
Another Proposed Case of Transdifferentiation
from Known Progenitor Cells
In rodents, a class of glial progenitors can be isolated from the optic nerve that
normally have the ability to produce only oligodendrocytes and some astrocytes
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(Kondo & Raff 2000). However, when these O2A cultures are exposed to BMP2
or 10% fetal calf serum and then switched into the type of culture medium that
enables the development of neurospheres, these cells, too, can give rise to neu-
rospheres that generate neurons, astrocytes, and oligodendrocytes (Kondo & Raff
2000). However, in this experiment, it remains possible that a rare subpopu-
lation of bFGF-responsive uncommitted cells are responsible for the trilineage
outcome.
A Case of Transdifferentiation of Prospectively Isolated
Hematopoietic Stem Cells to Liver in Adults Undergoing
Induced Liver Degeneration and Regeneration
Mice bearing the most common class of mutations found in human hereditary
tyrosinemia patients [inactivation of fumaryl acetoacetic hydrolase (FAH)] usu-
ally undergo progressive cycles of liver degeneration, regeneration, and the de-
velopment of hepatocarcinomas (Grompe et al. 1995). This is almost certainly
the result of build-up of the tyrosine catabolites succinyl acetoacetic acid and fu-
maryl acetoacetic acid, which are toxic to both liver and kidney proximal tubules
(Grompe et al. 1995). Placing these mice on a tyrosine-free diet and providing
them with a drug (NTBC) that blocks the first step of catabolism of tyrosine
allows these transgenic mutant mice to survive (Grompe et al. 1995). Reintro-
duction of a tyrosine-containing diet along with withdrawal of NTBC leads to
programmed liver degeneration and death from hepatic failure (Grompe et al.
1995). KTLS HSC from FAHC LacZC male CD45 congenic donors were trans-
planted at limit dilution or at high-cell doses into lethally irradiated FAH− hosts; in
the limit dilution case, mice were rescued from hematopoietic failure with female
FAH− LacZ− CD45 congenic BM (Lagasse et al. 2000). These KTLS HSC ex-
pressed CD45, a molecule found normally only on all blood-forming cells, except
mature erythrocytes, and not found on other cell types in the body. When these
mice were later placed on tyrosine-containing diets and withdrawn from NTBC
for several cycles, LacZC Y chromosome-positive FAHC liver nodules made up
of albumin-producing E cadherin-positive hepatocytes were found (Lagasse et al.
2000). Using single-marker depletions and purifications, it was shown that the only
cells in mouse BM that could reconstitute donor-derived liver nodules were c-kitC
Sca-1C Lin− cells (Lagasse et al. 2000). Transplantation of whole BM from FAHC
LacZCmale mice not only gave rise to donor-derived liver regeneration, but these
mice had restored liver function that kept the hosts alive, even in the absence of
NTBC (Lagasse et al. 2000). Furthermore, the only mice showing donor-derived
hepatopoiesis also showed donor-derived hematopoiesis; no instances of donor-
derived hematopoiesis or hepatopoiesis alone were recorded (Lagasse et al. 2000).
Although the limit dilution experiments here imply that a single clonogenic HSC
can in this circumstance give rise to both blood and liver, these experiments need
to be carried out with either single-cell KTLS HSC transplants or with randomly
marked KTLS cells.
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In this case of liver regeneration, one can say with confidence that KTLS
HSC, presumably cells of mesodermal origin, regenerate liver epithelial cells,
presumably of endodermal origin. This brings up the question of what is the normal
source of liver stem cells during fetal development—KTLS HSC or endodermal-
committed cells? Although it has been demonstrated that endodermal buds trans-
planted reciprocally between same developmental stage quail and chicks can give
rise to donor-derived liver and pancreas, it is not clear whether the stem cell within
these endodermal buds are not HSC. In a classic case similar to this one, using
fetal thymic transwell cultures, early fetal thymic epithelium cultured with same
age thymic or non-thymic mesenchyme produced thymic lymphocytes in the ep-
ithelial side (Auerbach 1961). However, later studies demonstrated that within
similar dissociated thymic epithelia recently emigrated rare cells of hematopoietic
appearance were found and that it was these cells rather than the much more abun-
dant epithelial cells that gave rise to thymic lymphocytes (Moore & Owen 1967).
Rigorous purification of cells in the early embryonic endodermal region must be
attempted in order to identify the nature of the cell type or types in the bud that
gives rise to the first liver and pancreas cells.
These experiments call into question what we think we know about the em-
bryonic/fetal generation of each organ or tissue and whether the same or different
cell types remain for the regeneration of such cells and tissues. Given the ro-
bust transdifferentiation capacity of KTLS HSC in at least this case, one must
wonder whether KTLS HSC or another multipotent cell is responsible for other
reports of transdifferentiations or even of organism cloning from nuclei. Relevant
to this proposal is the recent demonstration that MPB KTLS HSC are present
in the blood with a residence time of 1–5 min (Wright et al. 2001; A. Wagers,
D. Wright & I.L. Weissman, in preparation). Because several hundred KTLS HSC
can be found in normal blood at any time, it is apparent that continual flux of
large numbers of HSC from bone marrow to blood to tissues may be occur-
ring every day. Thus isolation of cells from muscle, liver, mammary gland, or
even brain must be considered to be potentially contaminated with KTLS HSC.
Low-frequency readouts of tissue transdifferentiation or donor nucleus-derived
organism cloning might therefore derive not from most resident cells in the tis-
sue but from a rare set of pluripotent or multipotent cells passing through that
tissue.
Several other demonstrations of apparent transdifferentiation have been recor-
ded. Perhaps most striking is the demonstration that single cell-derived neuro-
spheres, when transplanted into genetically distinct mouse blastocysts or even into
early chick embryos, at very low frequency, give rise to a wide variety of epithe-
lial tissues (Clarke et al. 2000). In another example, neurospheres bearing clonal
retroviral markers upon transplantation into sublethally irradiated, fully allogeneic
mouse recipients resulted incredibly in a late switch of all hematopoiesis from host
to donor (Bjornson et al. 1999). Both of these remarkable experiments should be
repeated by independent laboratories, much in the way the KTLS HSC to liver
transdifferentiation should be repeated by independent laboratories.
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In another striking experiment, partially enriched Lin− Sca-1C hematopoietic
cells transplanted directly into the dying myocardium of recipients, in which
3–5 h previously the left anterior descending coronary arteries had been ligated, re-
sulted in robust regeneration of myocardium, endothelium, and endothelial smooth
muscle cells from the donor (Orlic et al. 2001). It will be critical to test whether
the Lin− ScaCBM cells responsible for these regenerations are HSC or some other
Lin− ScaC cells, of which there are many types in BM.
In many tissues, a rare subset of cells capable of excluding organic dyes such
as rhodamine 123 or Hoechst 33342 from cell cytoplasm (called the side pop-
ulation) can be prospectively isolated and shown to be enriched for progenitors
for blood formation or for muscle regeneration (Goodell et al. 1996). The BM
side population appears to be highly enriched for, but not entirely composed of,
KTLS HSC (Goodell et al. 1996). Side population cells from BM have been re-
ported to regenerate muscle and side population muscle cells to regenerate blood
(Gussoni et al. 1999, Jackson et al. 1999). It remains to be determined whether
these are cells committed normally to that organ’s regeneration, or in the case
of muscle origin, are these hematopoietic CD45C cells and myogenic CD45−
cells?
There are many reports of unseparated BM cells that have generated rare cells
in the brain or the blood vessels. In these cases, the identity of the cells within
the BM responsible for the transdifferentiation is not known, nor are the daughter
cells found in different organs yet shown to have functional characteristics of
resident mature cells in these organs. Much remains to be done with these types
of experimental models.
CONCLUSION
The advent of stem cell biology has revealed several unexpected principles, in-
cluding the likelihood that most if not all tissues are generated during fetal life and
regenerated in adult life from stem to progenitor to progeny cells. The application
of stem cell biology to clinical hematopoietic cell transplantation has allowed mas-
sive expansion of the disease indications for such stem cell transplantations, either
autologous or allogeneic, in preclinical animal models. Stem cell biology has been
applied to human hematopoietic cell transplantation as well, wherein the goal is
to allow the physician to use lethal doses of myeloablative drugs in an attempt to kill
all endogenous cancer cells thereby rescuing the patients with cancer free HSC. The
recent flurry of papers claiming adult regeneration of non-hematopoietic tissues
and transdifferentiation and regeneration in these tissues provides great promise
that these too will be translated into clinical therapies. But we must require that
both the scientists and the translators of such science to clinical medicine refrain
from using confusing jargon and that they must be as rigorous in substantiating
their claims of stem cell isolation and stem cell transdifferentiation as the highest
standard used by fundamental stem cell biologists.
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Figure 1 Proposed model of major hematopoietic maturation pathways from HSC. Long-
term HSC (LT-HSC) give rise to short-term (ST) HSC. We propose that ST-HSC give rise
to at least CLP, which can form all cells of the lymphoid lineage, and CMP, which can
differentiate into either GMP or MEP, which form the cells of the granulocyte/macrophage or
megakaryocyte/erythroid lineages, respectively. The three myeloid progenitor subsets should
make up the vast majority of myeloid progenitor activity in steady-state bone marrow because
the Sca-1− c-kitC fraction, which is composed of GMP, MEP, and CMP, and the Sca-1C c-kitC
HSC fraction, were estimated to contain98% of myeloid colony-forming activity within the
Lin- IL-7R- fraction (data not shown). (From Nature 404: 193–97, 2000, with permission)
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Figure 2 See legend on next page
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Figure 2 (See figure on previous page) (opposite page) Unresolved issues about trans-
differentiation. (1) Extent of phenotypic conversion. In this and in all of the following
examples, tissue X contains a stem cell (square) that ordinarily differentiates into a cell
type (diamond ) appropriate for tissue (a), whereas tissue Y contains another stem cell
(circle) that ordinarily differentiates into a different cell type (triangle) appropriate for
that tissue (d). (c) Complete conversion of stem cell X into the differentiated cell type
characteristic of tissue Y (triangle) might occur upon transplantation. (b) Transplanted
stem cell X might also have differentiated to a cell expressing some phenotypic mark-
ers characteristic of tissue Y (shaded square), but did not actually undergo complete
differentiation to the functional cell type characteristic of tissue Y (shaded triangle).
Current experiments often do no distinguish these alternative possibilities. (2) Origin
of transdifferentiating cells. (a) Tissue X contains a stem cell (square) that normally
generates cell types characteristic of that tissue (diamond). (b) Upon transplantation
of a mixed population of cells from tissue X, one type of stem cell (square) might
transdifferentiate to cells characteristic of tissue Y (shaded triangle). (c) Upon trans-
plantation of a mixed population of cells from tissue X, the differentiated cell type
characteristic of tissue Y (triangle) might derive not from the stem cell for tissue X
(square), but from another, unknown progenitor cell present in the mixed population
(oval). (d) Tissue Y contains stem cells that normally generate cell types characteristic
of that tissue (triangle). (3) Transdifferentiation requires prior reprogramming in vitro.
(3a) In vivo, stem cell X does not have the capacity to differentiate to cells character-
istic of tissue Y (b). (3b) In vitro, stem cell X undergoes reprogramming (a) to acquire
the capacity to differentiate to cell types characteristic of tissue Y (b). (4) Significance
of low-frequency of phenotypic conversion. In both cases, only 1% of the cells in an
isolated stem cell population from tissue X undergo conversion to cell types charac-
teristic of tissue Y upon transplantation. (4a) The low frequency of the event reflects
a minority subpopulation of stem cells within the isolated population (gold square)
that has the capacity to transdifferentiate (d); the majority of the isolated stem cells
(open square) do not have the capacity to transdifferentiate (b). (4b) The isolated stem
cell population from tissue X is homogeneous (open square), but these cells undergo
transdifferentiation with a very low probability (b, p D 0.01) and 99% of the time do
not undergo such transdifferentiation (a).
A
nn
u.
 R
ev
. C
el
l. 
D
ev
. B
io
l. 
20
01
.1
7:
38
7-
40
3.
 D
ow
nl
oa
de
d 
fro
m
 a
rjo
urn
als
.an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: FRK
September 11, 2001 11:18 Annual Reviews AR139-FM
Annual Review of Cell and Developmental Biology
Volume 17, 2001
CONTENTS
CHEMICAL AND BIOLOGICAL STRATEGIES FOR ENGINEERING CELL
SURFACE GLYCOSYLATION, Eliana Saxon and Carolyn Bertozzi 1
THROMBOSPONDINS: MULTIFUNCTIONAL REGULATORS OF CELL
INTERACTIONS, Josephine C. Adams 25
SALMONELLA INTERACTIONS WITH HOST CELLS: TYPE III SECRETION
AT WORK, Jorge E. Gala´n 53
PATTERNING MECHANISMS CONTROLLING VERTEBRATE LIMB
DEVELOPMENT, Javier Capdevila and Juan Carlos Izpisu´a Belmonte 87
IDENTIFICATION OF SELF THROUGH TWO-DIMENSIONAL CHEMISTRY
AND SYNAPSES, Michael L. Dustin, Shannon K Bromley, Mark M. Davis,
and Cheng Zhu 133
POLARIZED CELL GROWTH IN HIGHER PLANTS, Peter Hepler, L. Vidali,
and A. Cheung 159
BOUNDARIES IN DEVELOPMENT: FORMATION AND FUNCTION,
Kenneth D. Irvine and Cordelia Rauskolb 189
MOLECULAR BASES OF CIRCADIAN RHYTHMS, Stacey L. Harmer,
Satchidananda Panda, and Steve A. Kay 215
EARLY EYE DEVELOPMENT IN VERTEBRATES, Robert L. Chow and
Richard A. Lang 255
RNP LOCALIZATION AND TRANSPORT IN YEAST, Pascal Chartrand,
Robert H. Singer, and Roy M. Long 297
VERTEBRATE SOMITOGENESIS, Olivier Pourquie´ 311
ANIMAL CELL CYTOKINESIS, Michael Glotzer 351
STEM AND PROGENITOR CELLS: ORIGINS, PHENOTYPES, LINEAGE
COMMITMENTS, AND TRANSDIFFERENTIATIONS, Irving L. Weissman,
David J. Anderson, and Fred Gage 387
RECENT ADVANCES IN CHEMICAL APPROACHES TO THE STUDY OF
BIOLOGICAL SYSTEMS, Michael A. Shogren-Knaak, Peter J. Alaimo,
and Kevan M. Shokat 405
EMBRYO-DERIVED STEM CELLS: OF MICE AND MEN, Austin G. Smith 435
vii
A
nn
u.
 R
ev
. C
el
l. 
D
ev
. B
io
l. 
20
01
.1
7:
38
7-
40
3.
 D
ow
nl
oa
de
d 
fro
m
 a
rjo
urn
als
.an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: FRK
September 11, 2001 11:18 Annual Reviews AR139-FM
viii CONTENTS
HOW MATRIX METALLOPROTEINASES REGULATE CELL BEHAVIOR,
Mark D. Sternlicht and Zena Werb 463
BIOLOGICAL BASKET WEAVING: FORMATION AND FUNCTION OF
CLATHRIN-COATED VESICLES, Frances M. Brodsky, Chih-Ying Chen,
Christine Knuehl, Mhairi C. Towler, and Diane E. Wakeham 517
GETTING THE MESSAGE ACROSS: THE INTRACELLULAR
LOCALIZATION OF mRNAS IN HIGHER EUKARYOTES,
Isabel M. Palacios and Daniel St. Johnston 569
CELLULAR FUNCTION OF PHOSPHOINOSITIDE 3-KINASES:
IMPLICATIONS FOR DEVELOPMENT, IMMUNITY, HOMEOSTASIS, AND
CANCER, Roy Katso, Klaus Okkenhaug, Khatereh Ahmadi, Sarah White,
John Timms, and Michael D. Waterfield 615
CONTROL OF EARLY SEED DEVELOPMENT, Adbul M. Chaudhury, Anna
Koltunow, Thomas Payne, Ming Luo, Mathew R. Tucker, E. S. Dennis,
and W. J. Peacock 677
PEROXISOME BIOGENESIS, P. Edward Purdue and Paul B. Lazarow 701
THE MOLECULAR BASIS OF SISTER-CHROMATID COHESION,
Janice Y. Lee and Terry L. Orr-Weaver 753
LEFT-RIGHT ASYMMETRY DETERMINATION IN VERTEBRATES,
Mark Mercola and Michael Levin 779
INDEXES
Subject Index 807
Cumulative Index of Contributing Authors, Volumes 13–17 841
Cumulative Index of Chapter Titles, Volumes 13–17 844
ERRATA
An online log of corrections to Annual Review of Cell and Developmental
Biology chapters may be found http://cellbio.AnnualReviews.org/errata.shtml
A
nn
u.
 R
ev
. C
el
l. 
D
ev
. B
io
l. 
20
01
.1
7:
38
7-
40
3.
 D
ow
nl
oa
de
d 
fro
m
 a
rjo
urn
als
.an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
